 2. or Patients must have had progressive disease after therapy with an immune checkpoint inhibitor and platinum-based chemotherapy either 1st line chemotherapy followed by 2nd line checkpoint inhibitor, or 1st line checkpoint inhibitor followed by 2nd line chemotherapy, or 1st line combination of checkpoint inhibitor and chemotherapy 